After $14B exit, Karuna co-founder finds next bet; Ex-Regenxbio CEO Ken Mills heads to Tagworks
Andrew Miller has quickly made his first move after the technology he invented, KarXT, secured an FDA approval last week.
The regulator’s nod for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
